MarketInOut Stock Screener Log In | Sign Up
 

Glaukos Corp

NYSE • Healthcare • Medical Devices • Quote as of 06/26/2026 16:00
Glaukos Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization8,091.18 mln
Float57.71 mln
Earnings Date08/05/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.91
Likely reliable

1-Year Forecast

158
Modest upside

Relative Strength

97 / 100
Top performer

Debt / Equity

0.15
Very low leverage

ROE

-26.11
Deeply negative

Business Description

Glaukos Corporation is a medical technology and eye care company based in Aliso Viejo, California, that develops treatments for glaucoma, corneal conditions, and retinal diseases across the United States and global markets. The company offers a range of products including tiny implants that help fluid drain from the eye to lower pressure in glaucoma patients, a drug-releasing device placed inside the eye, and a treatment for a condition that causes the cornea to thin and bulge. Glaukos also works on a skin-applied eyelid cream that delivers medication without eye drops, as well as therapies targeting serious retinal diseases such as age-related macular degeneration. Its products are sold to surgery centers, hospitals, and private eye care practices through both direct sales teams and distribution partners.

Key Fundamentals

EPS-3.31
ROE-26.11
RPS9.58
ROIC-32.27
ROA-19.97
EBITDA, mln-144
EV / EBITDA-45.69
EV / EBIT-34.64
Revenue, mln551
EV / Revenue11.93

Financial Strength

Altman Z-Score18.01
Piotroski F-Score 3 / 9
Beneish M-Score-2.91
1-Year Target Price158
Short Ratio2.63
Short % of Float6.44

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 10.51% 97 / 100   
1 Month 31.43% 99 / 100   
2 Months 41.46% 95 / 100   
6 Months 24.31% 86 / 100   
1 Year 45.42% 85 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us